Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas.

Kavitha P. Raj,Jason A. Zell,Cheryl L. Rock,Christine E. McLaren,Christine Zoumas-Morse,Eugene W. Gerner,Frank L. Meyskens

Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas.

2013

Kavitha P. Raj
Jason A. Zell
Cheryl L. Rock
Christine E. McLaren
Christine Zoumas-Morse
Eugene W. Gerner
Frank L. Meyskens

Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas

Keywords:

Clinical trial
Randomized controlled trial
Medicine
Colorectal adenoma
Cancer prevention
Adenoma
Pathology
Sulindac
Survival rate
Eflornithine
Polyamine
Spermidine
Spermine
Quartile
Relative risk

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations